Tempest Therapeutics, Inc. Deferred Compensation Arrangement with Individual, Cash Award Granted, Amount
Tempest Therapeutics, Inc. (TPST) had Deferred Compensation Arrangement with Individual, Cash Award Granted, Amount of $800.00 thousand as of 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Notes › Compensation Related Costs
us-gaap:DeferredCompensationArrangementWithIndividualCashAwardGrantedAmount · last filed 2018-03-15
- 2017-12-31: Deferred Compensation Arrangement with Individual, Cash Award Granted, Amount $800.00K.
- 2017-09-30: Deferred Compensation Arrangement with Individual, Cash Award Granted, Amount $800.00K.
- 2017-06-30: Deferred Compensation Arrangement with Individual, Cash Award Granted, Amount $800.00K.
| Period end | Deferred Compensation Arrangement with Individual, Cash Award Granted, Amount |
|---|---|
| 2017-12-31 | $800.00K 10-K · filed 2018-03-15 |
| 2017-09-30 | $800.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | $800.00K 10-Q · filed 2017-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |